Zeitschriftenartikel zum Thema „MEIS Inhibitors“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "MEIS Inhibitors" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Kocabas, F., S. N. Eren, M. Uslu und M. Y. Yuksel. „P69Identification of cardiogenic and hematopoietic MEIS Inhibitors“. Cardiovascular Research 114, suppl_1 (01.04.2018): S18—S19. http://dx.doi.org/10.1093/cvr/cvy060.033.
Der volle Inhalt der QuelleGİRGİN, Birkan, Medine KARADAĞ-ALPASLAN und Fatih KOCABAŞ. „Oncogenic and tumor suppressor function of MEIS and associated factors“. TURKISH JOURNAL OF BIOLOGY 44, Nr. 6 (14.12.2020): 328–55. http://dx.doi.org/10.3906/biy-2006-25.
Der volle Inhalt der QuelleBarbosa, Karina, Anagha Deshpande, Ping Xiang, Bo-Rui Chen, Adam Brown, Neil Robertson, Younguk Sun et al. „High-Density Domain-Focused CRISPR Screens Reveal Epigenetic Regulators of Hox/Meis Gene Expression in Acute Myeloid Leukemia“. Blood 136, Supplement 1 (05.11.2020): 2–3. http://dx.doi.org/10.1182/blood-2020-141412.
Der volle Inhalt der QuelleBisaillon, Richard, Eva Schmidt, Anne-Sophie Guenier und Guy Sauvageau. „Identification of MEIS-PBX inhibitors as potential anti-leukemic agents using a high-throughput bret-based assay“. Experimental Hematology 41, Nr. 8 (August 2013): S51. http://dx.doi.org/10.1016/j.exphem.2013.05.201.
Der volle Inhalt der QuelleCastellet, Helena, Guillermo Ramil López, Ana Garrido, Alícia Artigas-Baleri, Marta Pratcorona, Olga Salamero, Albert Cortés-Bullich et al. „Ubtf tandem Duplications Define a Novel Subtype of Acute Myeloid Leukemia Associated with Younger Age, WT1 Mutations and HOXA9 Marked Overexpression“. Blood 142, Supplement 1 (28.11.2023): 6045. http://dx.doi.org/10.1182/blood-2023-186064.
Der volle Inhalt der QuelleBreitinger, Constanze, Emanuel Maethner, Maria-Paz Garcia-Cuellar, Alexandra Schambony, Kirsten Schilling, Klaus D. Fischer und Robert K. Slany. „Hox Genes Regulate Rac1 Activity Through Control of Vav2 expression“. Blood 118, Nr. 21 (18.11.2011): 60. http://dx.doi.org/10.1182/blood.v118.21.60.60.
Der volle Inhalt der QuelleJarocha, Danuta Jadwiga, Paul Gadue, Wei Tong, Robert C. Newton und Mortimer Poncz. „Janus Kinase (Jak) 1 Inhibition Affects Both Megakaryopoiesis and Thrombopoiesis“. Blood 132, Supplement 1 (29.11.2018): 2559. http://dx.doi.org/10.1182/blood-2018-99-115407.
Der volle Inhalt der QuelleHaneline, Laura S., Khadijeh R. Bijangi-Vishehsaraei, Adam Werne, Kristina Wilson McKenzie, Susanna Davis, Hidenori Ichijo und Mohammad R. Saadatzadeh. „TNF-α Hypersensitivity of Fanconi Anemia Type C Deficient Cells Is Dependent on the Apoptosis Signal-Regulating Kinase 1 Signaling Pathway.“ Blood 104, Nr. 11 (16.11.2004): 724. http://dx.doi.org/10.1182/blood.v104.11.724.724.
Der volle Inhalt der QuelleWang, Wei, Peng Li, Annette Schettino, Zhe Peng und Maureen McLeod. „Characterization of Functional Regions in the Schizosaccharomyces pombe mei3 Developmental Activator“. Genetics 150, Nr. 3 (01.11.1998): 1007–18. http://dx.doi.org/10.1093/genetics/150.3.1007.
Der volle Inhalt der QuelleKAYA, Mustafa Oğuzhan. „Out-of-mind Inhibitors Of Human Serum Paraoxonase 1 (PON1): An In Vitro study“. Middle East Journal of Science 3, Nr. 1 (26.08.2017): 59–77. http://dx.doi.org/10.23884/mejs.2017.3.1.07.
Der volle Inhalt der QuelleAgarwal, Archana, Gregory Russell Pond, Catherine Curran, Amin Nassar, Pier Vitale Nuzzo, Vivek Kumar, Bradley Alexander McGregor et al. „Impact of concurrent medications on outcomes with PD1/PD-L1 inhibitors for metastatic urothelial carcinoma.“ Journal of Clinical Oncology 37, Nr. 7_suppl (01.03.2019): 435. http://dx.doi.org/10.1200/jco.2019.37.7_suppl.435.
Der volle Inhalt der QuelleAltman, Jessica K., Heather Glaser, Amanda Redig, Antonella Sassano, Martin S. Tallman und Leonidas C. Platanias. „Targeting the Mnk Pathway Enhances Chemotherapy-Induced Antileukemic Responses.“ Blood 112, Nr. 11 (16.11.2008): 1617. http://dx.doi.org/10.1182/blood.v112.11.1617.1617.
Der volle Inhalt der QuelleWaters, Andrew Michael, Wen-Hsuan Chang, Clint Stalnecker, Cole Edwards, Runying Yang, Craig M. Goodwin, Adrienne D. Cox und Channing J. Der. „Abstract 1075: Identification of resistance mechanisms to direct KRAS inhibition in pancreatic cancer“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 1075. http://dx.doi.org/10.1158/1538-7445.am2023-1075.
Der volle Inhalt der QuelleMattos, Daphne R., Xuemei Wan, Jeffrey D. Serrill, Minh H. Nguyen, Ian R. Humphreys, Benoit Viollet, Amos B. Smith, Kerry L. McPhail und Jane E. Ishmael. „The Marine-Derived Macrolactone Mandelalide A Is an Indirect Activator of AMPK“. Marine Drugs 20, Nr. 7 (27.06.2022): 418. http://dx.doi.org/10.3390/md20070418.
Der volle Inhalt der QuelleDelgado, Irene, Alejandra C. López-Delgado, Alberto Roselló-Díez, Giovanna Giovinazzo, Vanessa Cadenas, Laura Fernández-de-Manuel, Fátima Sánchez-Cabo, Matthew J. Anderson, Mark Lewandoski und Miguel Torres. „Proximo-distal positional information encoded by an Fgf-regulated gradient of homeodomain transcription factors in the vertebrate limb“. Science Advances 6, Nr. 23 (Juni 2020): eaaz0742. http://dx.doi.org/10.1126/sciadv.aaz0742.
Der volle Inhalt der QuelleSchevzov, Galina, Anthony J. Kee, Bin Wang, Vanessa B. Sequeira, Jeff Hook, Jason D. Coombes, Christine A. Lucas et al. „Regulation of cell proliferation by ERK and signal-dependent nuclear translocation of ERK is dependent on Tm5NM1-containing actin filaments“. Molecular Biology of the Cell 26, Nr. 13 (Juli 2015): 2475–90. http://dx.doi.org/10.1091/mbc.e14-10-1453.
Der volle Inhalt der QuelleIhlefeld, Katja, Ralf Frederik Claas, Alexander Koch, Josef M. Pfeilschifter und Dagmar Meyer zu Heringdorf. „Evidence for a link between histone deacetylation and Ca2+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts“. Biochemical Journal 447, Nr. 3 (05.10.2012): 457–64. http://dx.doi.org/10.1042/bj20120811.
Der volle Inhalt der QuelleHamaguchi, Yukiyoshi, Steven K. Juhn und Yasuo Sakakura. „Protease Inhibitors in Middle Ear Effusions from Experimental Otitis Media with Effusion: Kinetics of α1-Antitrypsin and α2-Macroglobulin Levels“. Annals of Otology, Rhinology & Laryngology 98, Nr. 4 (April 1989): 287–92. http://dx.doi.org/10.1177/000348948909800410.
Der volle Inhalt der QuelleKundu, Mondira, Chia-Ying Yang, Kelly McCastlain, Junmin Wu, Ji Zhang, Tullia Lindsten, Paul Ney und Craig B. Thompson. „Hsp90 regulates Ulk1-mediated autophagic clearance of mitochondria“. Blood 112, Nr. 11 (16.11.2008): 3458. http://dx.doi.org/10.1182/blood.v112.11.3458.3458.
Der volle Inhalt der QuelleWeddle, Carly, und Paul Burridge. „Abstract A070: Examining patient-specific responses to PARP inhibitors in a novel, human induced pluripotent stem cell-based model of breast cancer“. Cancer Research 84, Nr. 3_Supplement_1 (01.02.2024): A070. http://dx.doi.org/10.1158/1538-7445.advbc23-a070.
Der volle Inhalt der QuelleYu, Lanlan, Baohui Wang, Xurui Sun und Jian Song. „Synthesis and properties of a MEAS quadripolymer scale inhibitor“. Desalination and Water Treatment 52, Nr. 10-12 (16.05.2013): 1865–71. http://dx.doi.org/10.1080/19443994.2013.792014.
Der volle Inhalt der QuelleRenaldo, Kyle, Shelby Sloan, JiHyun Chung, Lindsay Courtney, Konstantin Shilo, William Kisseberth und Robert A. Baiocchi. „Exploring PRMT5 As a Potential Therapeutic Target in Canine Lymphomas“. Blood 132, Supplement 1 (29.11.2018): 4182. http://dx.doi.org/10.1182/blood-2018-99-119115.
Der volle Inhalt der QuelleAlexander, D. L., L. G. Ganem, P. Fernandez-Salguero, F. Gonzalez und C. R. Jefcoate. „Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis“. Journal of Cell Science 111, Nr. 22 (15.11.1998): 3311–22. http://dx.doi.org/10.1242/jcs.111.22.3311.
Der volle Inhalt der QuelleLambert, Michele P., Yuhuan Wang, M. Anna Kowalska und Mortimer Poncz. „Negative Paracrine Effect of Platelet Factor 4 on Megakaryopoiesis Occurs through Lipoprotein Related Protein Receptor-1 on Megakaryocytes.“ Blood 110, Nr. 11 (16.11.2007): 97. http://dx.doi.org/10.1182/blood.v110.11.97.97.
Der volle Inhalt der QuelleKhan, Husain Yar, Sahar Bannoura, Hirva Mamdani, Amro Aboukameel, Yousef Mzannar, Yiwei Li, Mohammad Najeeb Al-Hallak et al. „Abstract 5315: Anti-tumor activity of KRASG12C inhibitors is enhanced when combined with Cdc42 effector p21-activated kinase 4 targeting agents“. Cancer Research 82, Nr. 12_Supplement (15.06.2022): 5315. http://dx.doi.org/10.1158/1538-7445.am2022-5315.
Der volle Inhalt der QuelleNigam, Aradhya, Walid K. Chatila, Gnana P. Krishnamoorthy, Alan L. Ho, James A. Fagin, Nikolaus D. Schultz und Brian R. Untch. „Abstract 1181: PTEN loss-of-function mutations prevalent in HRAS-mutant cancers results in resistance to targeted therapy“. Cancer Research 82, Nr. 12_Supplement (15.06.2022): 1181. http://dx.doi.org/10.1158/1538-7445.am2022-1181.
Der volle Inhalt der QuelleZhou, Yang, Sahar Alimohamadi, Li Wang, Ziqing Liu, Joseph B. Wall, Chaoying Yin, Jiandong Liu und Li Qian. „A Loss of Function Screen of Epigenetic Modifiers and Splicing Factors during Early Stage of Cardiac Reprogramming“. Stem Cells International 2018 (2018): 1–14. http://dx.doi.org/10.1155/2018/3814747.
Der volle Inhalt der QuelleTanajura, Luiz, Áurea Chaves, Andrea Abizaid und José Costa Júnior. „Monotherapy with P2Y12 receptor inhibitors in patients treated by percutaneous coronary intervention“. Journal of Transcatheter Interventions 29 (02.12.2021): 1–9. http://dx.doi.org/10.31160/jotci202129a202106.
Der volle Inhalt der QuelleDinchuk, Joseph E., Carolyn Cao, Fei Huang, Karen A. Reeves, Jeanne Wang, Fanny Myers, Glenn H. Cantor et al. „Insulin Receptor (IR) Pathway Hyperactivity in IGF-IR Null Cells and Suppression of Downstream Growth Signaling Using the Dual IGF-IR/IR Inhibitor, BMS-754807“. Endocrinology 151, Nr. 9 (07.07.2010): 4123–32. http://dx.doi.org/10.1210/en.2010-0032.
Der volle Inhalt der QuelleHamaguchi, Yukiyoshi, Yuichi Majima, Kenji Sakakura und Yasuo Sakakura. „Lysosomal Thiol Proteases in Middle Ear Effusions“. Annals of Otology, Rhinology & Laryngology 95, Nr. 3_suppl (Mai 1986): 9–12. http://dx.doi.org/10.1177/00034894860950s303.
Der volle Inhalt der QuelleDizaye, Kawa F., und Asmaa A. Ahmed. „Renoprotective Evaluations of Different Angiotensin Inhibitors on Diabetic Nephropathy in Rats“. Middle East Journal of Internal Medicine 9, Nr. 3 (November 2016): 3–11. http://dx.doi.org/10.5742/meim.2016.92897.
Der volle Inhalt der QuelleMack, Fiona A., Jagruti H. Patel, Mangatt P. Biju, Volker H. Haase und M. Celeste Simon. „Decreased Growth of Vhl−/− Fibrosarcomas Is Associated with Elevated Levels of Cyclin Kinase Inhibitors p21 and p27“. Molecular and Cellular Biology 25, Nr. 11 (01.06.2005): 4565–78. http://dx.doi.org/10.1128/mcb.25.11.4565-4578.2005.
Der volle Inhalt der QuelleShim, Sungbo, Yujin Kim, Jongdae Shin, Jieun Kim und Soochul Park. „Regulation of EphA8 Gene Expression by TALE Homeobox Transcription Factors during Development of the Mesencephalon“. Molecular and Cellular Biology 27, Nr. 5 (18.12.2006): 1614–30. http://dx.doi.org/10.1128/mcb.01429-06.
Der volle Inhalt der QuelleSun, Jun, Juan Kong, Yingli Duan, Frances L. Szeto, Anne Liao, James L. Madara und Yan Chun Li. „Increased NF-κB activity in fibroblasts lacking the vitamin D receptor“. American Journal of Physiology-Endocrinology and Metabolism 291, Nr. 2 (August 2006): E315—E322. http://dx.doi.org/10.1152/ajpendo.00590.2005.
Der volle Inhalt der QuelleYerlikaya, Azmi, Scot R. Kimball und Bruce A. Stanley. „Phosphorylation of eIF2α in response to 26S proteasome inhibition is mediated by the haem-regulated inhibitor (HRI) kinase“. Biochemical Journal 412, Nr. 3 (28.05.2008): 579–88. http://dx.doi.org/10.1042/bj20080324.
Der volle Inhalt der QuelleSaadatzadeh, M. Reza, Khadijeh Bijangi-Vishehsaraei und Laura S. Haneline. „The Role of Stress Activated Protein Kinases in Promoting Fanconi Anemia Hematopoietic Stem and Progenitor Cell Dysfunction“. Blood 112, Nr. 11 (16.11.2008): 1043. http://dx.doi.org/10.1182/blood.v112.11.1043.1043.
Der volle Inhalt der QuelleIshida, Yoji, Syugo Kowata, Kazunori Murai, Tatsuo Oyake und Shigeki Ito. „TAT/HDL Induces the Phospholylation of Cofilin in the Process of Platelet Production of Megakaryocytes.“ Blood 104, Nr. 11 (16.11.2004): 2186. http://dx.doi.org/10.1182/blood.v104.11.2186.2186.
Der volle Inhalt der QuelleSealover, Nancy, Bridget Finniff und Robert Kortum. „Abstract B033: Wild-type RAS signaling is an essential therapeutic target in RAS-mutated cancers“. Molecular Cancer Research 21, Nr. 5_Supplement (01.05.2023): B033. http://dx.doi.org/10.1158/1557-3125.ras23-b033.
Der volle Inhalt der QuelleRubin, Elina, Agnese C. Pippione, Matthew Boyko, Giacomo Einaudi, Stefano Sainas, Massimo Collino, Carlo Cifani et al. „A New NF-κB Inhibitor, MEDS-23, Reduces the Severity of Adverse Post-Ischemic Stroke Outcomes in Rats“. Brain Sciences 12, Nr. 1 (28.12.2021): 35. http://dx.doi.org/10.3390/brainsci12010035.
Der volle Inhalt der QuelleGRILL, Constance, Ferdous GHEYAS, Priya DAYANANTH, Weihong JIN, Wei DING, Ping QIU, Luquan WANG, Ronald J. DOLL und Jessie M. ENGLISH. „Analysis of the ERK1,2 transcriptome in mammary epithelial cells“. Biochemical Journal 381, Nr. 3 (27.07.2004): 635–44. http://dx.doi.org/10.1042/bj20031688.
Der volle Inhalt der QuelleTergaonkar, Vinay, Virginie Bottero, Masahito Ikawa, Qiutang Li und Inder M. Verma. „IκB Kinase-Independent IκBα Degradation Pathway: Functional NF-κB Activity and Implications for Cancer Therapy“. Molecular and Cellular Biology 23, Nr. 22 (15.11.2003): 8070–83. http://dx.doi.org/10.1128/mcb.23.22.8070-8083.2003.
Der volle Inhalt der QuelleTanajura, Luiz, Áurea Chaves, Rafaela Freitas, Ana Barbosa, Kelvyn Vital und José Delamain. „Aspirin versus P2Y12 inhibitors for secondary prevention after percutaneous coronary intervention“. Journal of Transcatheter Interventions 31 (14.12.2023): 1–7. http://dx.doi.org/10.31160/jotci202331a202304.
Der volle Inhalt der QuelleVanzyl, Erin J., Hadil Sayed, Alex B. Blackmore, Kayleigh R. C. Rick, Pasan Fernando und Bruce C. McKay. „The spliceosome inhibitors isoginkgetin and pladienolide B induce ATF3-dependent cell death“. PLOS ONE 15, Nr. 12 (28.12.2020): e0224953. http://dx.doi.org/10.1371/journal.pone.0224953.
Der volle Inhalt der QuelleMukherjee, Kaustav, Bruce Futcher und Janet Leatherwood. „mmi1 and rep2 mRNAs are novel RNA targets of the Mei2 RNA-binding protein during early meiosis in Schizosaccharomyces pombe“. Open Biology 8, Nr. 9 (September 2018): 180110. http://dx.doi.org/10.1098/rsob.180110.
Der volle Inhalt der QuelleGreene, Teshell K., Li Zhai, Beatrice Razzo, Karen Vo, Denise E. Sabatino, Rodney M. Camire, Valder R. Arruda und Mortimer Poncz. „Platelet Factor VIII-Induced Megakaryocyte Apoptosis: Implications for Hemophilia A Gene Therapy“. Blood 120, Nr. 21 (16.11.2012): 2051. http://dx.doi.org/10.1182/blood.v120.21.2051.2051.
Der volle Inhalt der QuelleKariya, Shin, Mitsuhiro Okano, Katsuya Aoji, Michiya Kosaka, Emiko Chikumoto, Hisashi Hattori, Koji Yuen, Shinji Nishioka, Keiko Nishioka und Kazunori Nishizaki. „Role of Macrophage Migration Inhibitory Factor in Otitis Media with Effusion in Adults“. Clinical Diagnostic Laboratory Immunology 10, Nr. 3 (Mai 2003): 417–22. http://dx.doi.org/10.1128/cdli.10.3.417-422.2003.
Der volle Inhalt der QuelleÇAKMAK, Reşit, Ercan ÇINAR, Eyüp BAŞARAN und Mehmet BOĞA. „SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL EVALUATION OF ESTER DERIVATIVES OF 4-(DIETHYLAMINO)SALICYLALDEHYDE AS CHOLINESTERASE, AND TYROSINASE INHIBITORS“. Middle East Journal of Science 7, Nr. 2 (30.12.2021): 137–44. http://dx.doi.org/10.51477/mejs.947973.
Der volle Inhalt der QuelleLuciana, Luciana, Firdha Senja Maelaningsih und Diah Permata Sari. „PENGGUNAAN PROTON PUMP INHIBITOR PADA PASIEN RAWAT JALAN DI RSIA DHIA CIPUTAT TANGERANG SELATAN“. Edu Masda Journal 6, Nr. 1 (18.04.2022): 36. http://dx.doi.org/10.52118/edumasda.v6i1.151.
Der volle Inhalt der QuelleSealover, Nancy E., und Robert L. Kortum. „Abstract 413: WT RAS signaling is an essential therapeutic target in RAS mutated cancers“. Cancer Research 82, Nr. 12_Supplement (15.06.2022): 413. http://dx.doi.org/10.1158/1538-7445.am2022-413.
Der volle Inhalt der QuelleMinami, Kahori, Yukihiro Tambe, Ryosuke Watanabe, Takahiro Isono, Masataka Haneda, Ken-ichi Isobe, Toshiyuki Kobayashi et al. „Suppression of Viral Replication by Stress-Inducible GADD34 Protein via the Mammalian Serine/Threonine Protein Kinase mTOR Pathway“. Journal of Virology 81, Nr. 20 (01.08.2007): 11106–15. http://dx.doi.org/10.1128/jvi.01063-07.
Der volle Inhalt der Quelle